Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19). We conducted a randomized, open-label, phase 3 ...

FOSTER CITY, Calif. -- The world's largest randomized trial of COVID-19 treatments found "conclusive evidence" that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has ...

Antiviral treatment with remdesivir and/or nirmatrelvir/ritonavir within 3 days of hospital admission was associated with a significant reduction in mortality among patients hospitalised with acute ...

The US Food and Drug Administration approved remdesivir for the treatment of coronavirus infection, the drug's maker, Gilead Sciences, said Thursday. The drug, sold under the brand name Veklury, has ...

BERLIN, Nov 3 (Reuters) - Germany's health minister defended on Tuesday his decision to purchase additional supplies of remdesivir for treating COVID-19, saying Gilead's (GILD.O), opens new tab ...

Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were ...

Dec 11 (Reuters) - Europe's drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a COVID-19 treatment, to make clear the ...

As lockdowns ease across the United States, millions of Americans are set to take tentative steps outdoors to celebrate Memorial Day. But public health officials are still concerned that if people ...